ADM and chronic kidney disease: Consistent with our findings, patients with chronic cardiorenal diseases have higher blood levels of ADM [63, 64] and PAI-1 [65–67], where the first is a potential biomarker of CKD progression [64, 68] and the latter a risk factor for cardiorenal disease [66, 69].